P-1 Refractoriness to cancer cell reprogramming unveils cancer type-specific therapeutic targets
Kohei Nagata
(Division of Stem Cell Pathology, Institute of Medical Science, University of Tokyo)
検索語句を入力の上、「検索を実行」ボタンをクリックしてください。
Kohei Nagata
(Division of Stem Cell Pathology, Institute of Medical Science, University of Tokyo)
Jumpei Taguchi
(Division of Stem Cell Pathology, Center for Experimental Medicine and Systems Biology, Institute of Medical Science, University of Tokyo)
Shin Ariga
(Department of Medical Oncology Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan)
Dini Kurnia Ikliptikawati
(Kanazawa University)
Michiko Kurikawa
(Cancer RNA Research Unit, National Cancer Center Research Institute)
Ayumu Suzuki
(Division of Developmental Biology, Research Center for Genomic Medicine, Saitama Medical University)